(Reuters) - The acquisition is expected to close in the third quarter of 2007, subject to regulatory and shareholder approval, and will add about $2 million to Qiagen's sales in the second half of 2007 and about $7 million to $9 million in 2008, Qiagen said.
One-time charges related to the deal are expected to reduce Qiagen's earnings per share by about $0.01 in the second half of 2007 and to be earnings-neutral in 2008. Margins are not expected to be materially affected.
Read more at Reuters.com Mergers News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment